This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Leland Stanford Junior University. Active years: 2015-2019.
Company Filing History:
Years Active: 2015-2019
Title: Innovations by Stanley G. Rockson
Introduction
Stanley G. Rockson is a prominent inventor based in Stanford, California. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of lymphedema. With a total of 2 patents, his work focuses on innovative therapeutic methods that address this condition.
Latest Patents
Rockson's latest patents include groundbreaking methods for treating lymphedema. The first patent, titled "LTB4 inhibition to prevent and treat human lymphedema," provides therapeutic methods for treating patients with lymphedema by inhibiting the synthesis activity of leukotriene B. The second patent, "Method for the treatment of acquired lymphedema," identifies genes that are differentially expressed in lymphedema tissues. This invention offers methods for diagnosing or assessing an individual's susceptibility to lymphedema and describes therapeutic methods for treating patients or prophylactically treating those at risk.
Career Highlights
Stanley G. Rockson is affiliated with Leland Stanford Junior University, where he conducts his research and develops his innovative solutions. His work has garnered attention for its potential to improve the quality of life for individuals suffering from lymphedema.
Collaborations
Rockson has collaborated with notable colleagues, including Raymond Tabibiazar and Mark R. Nicolls. These partnerships have contributed to the advancement of research in the field of lymphedema treatment.
Conclusion
Stanley G. Rockson's contributions to the field of medical research through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches to treating lymphedema are paving the way for new therapeutic options.